Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial

Dorling, J. L. et al. (2021) Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. European Journal of Nutrition, 60(3), pp. 1633-1643. (doi: 10.1007/s00394-020-02361-7) (PMID:32803412)

Full text not currently available from Enlighten.

Abstract

Purpose: Calorie restriction (CR) is an effective treatment for obesity-related liver and metabolic disease. However, CR studies in individuals without obesity are needed to see if CR could delay disease onset. Liver biomarkers indicate hepatic health and are linked to cardiometabolic disease. Our aim was to examine the effects of a 2-year CR intervention on liver biomarkers in healthy individuals without obesity. Methods: The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) study was a 2-year randomized controlled trial. Overall, 218 participants (body mass index: 25.1 ± 1.7 kg/m2) were enrolled into a control group (n = 75) that ate ad libitum (AL), or a CR group (n = 143) that aimed to decrease energy intake by 25%. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin were measured during the trial. Results: At month 24, relative to the AL group, ALP (− 7 ± 1 IU/L; P < 0.01) and GGT (− 0.11 ± 0.04 log IU/L; P = 0.02) decreased and bilirubin increased (0.21 ± 0.06 log mg/dL; P < 0.01) in the CR group; no between-group differences in ALT (− 1 ± 1 IU/L; P > 0.99) or AST (2 ± 2 IU/L; P = 0.68) were revealed. However, sex-by-treatment-by-time interactions (P < 0.01) were observed, with CR (vs. control) inducing reduced ALT and GGT and increased AST in men only (P ≤ 0.02). Conclusions: In metabolically healthy individuals without obesity, 2 years of CR improves several liver biomarkers, with potentially greater improvements in men. These data suggest that sustained CR may improve long-term liver and metabolic disease risk in healthy adults. Trial registration: Clinicaltrials.gov (NCT00427193). Registered January 2007.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Dorling, Dr James
Authors: Dorling, J. L., Ravussin, E., Redman, L. M., Bhapkar, M., Huffman, K. M., Racette, S. B., Das, S. K., Apolzan, J. W., Kraus, W. E., Höchsmann, C., and Martin, C. K.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:European Journal of Nutrition
Publisher:Springer
ISSN:1436-6207
ISSN (Online):1436-6215
Published Online:14 August 2020

University Staff: Request a correction | Enlighten Editors: Update this record